1. Home
  2. TFSL vs GPCR Comparison

TFSL vs GPCR Comparison

Compare TFSL & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

SELL

Current Price

$16.31

Market Cap

4.5B

Sector

Finance

ML Signal

SELL

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$20.98

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFSL
GPCR
Founded
1938
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.8B
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
TFSL
GPCR
Price
$16.31
$20.98
Analyst Decision
Hold
Strong Buy
Analyst Count
2
16
Target Price
$18.25
★ $105.78
AVG Volume (30 Days)
685.4K
★ 1.2M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 7.78%
N/A
EPS Growth
★ 14.29
N/A
EPS
★ 0.27
N/A
Revenue
N/A
N/A
Revenue This Year
$8.17
N/A
Revenue Next Year
$7.60
N/A
P/E Ratio
$60.52
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.91
$21.55
52 Week High
$19.49
$94.90

Technical Indicators

Market Signals
Indicator
TFSL
GPCR
Relative Strength Index (RSI) 41.48 13.66
Support Level $16.02 N/A
Resistance Level $16.96 $56.63
Average True Range (ATR) 0.27 1.58
MACD 0.02 -0.28
Stochastic Oscillator 37.69 2.01

Price Performance

Historical Comparison
TFSL
GPCR

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: